Shareholder Value and Financial Outlook
Reconciliation of GAAP to non-GAAP financial measures
Shareholders' net income and diluted earnings per share
Year Ended December 31, 2022
Shareholders' net income
Adjustments to reconcile to
Dollars in millions
Pre-Tax
Diluted earnings per
share
Dollars in millions
Diluted earnings per
share
Pre-Tax
After-Tax
After-Tax
$6,668
$21.30
adjusted income from operations:
Net realized investment losses*
$621
$1.98
$503
$1.61
Amortization of acquired
$1,876
$5.99
$1,345
$4.30
intangible assets
Special items
Integration and transaction-related costs
$135
$0.43
$103
$0.33
Charge for organizational efficiency plan
$22
$0.07
$17
$0.05
(Benefits) associated with litigation matters
$(28)
$(0.09)
$(20)
$(0.06)
(Gain) on sale of business
$(1,662)
$(5.31)
$(1,332)
$(4.26)
Adjusted income from operations
$7,284
$23.27
*Includes the Company's share of certain realized investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting.
Confidential, unpublishedproperty of Cigna. © 2023 CignaView entire presentation